David Tanen is a co-founder and Partner of Two River, where he has served as partner since its inception in 2004. David is also a Co-Founder of Kite Pharma, Inc., where he served as Corporate Secretary and General Counsel before its acquisition by Gilead Sciences in 2017. David is also a co-founder of Kronos Bio, Inc., and Neogene Therapeutics, Inc., each a privately held biotechnology company, where he serves as a member of the Board of Directors and Corporate Secretary. He is also a Co-Founder and Corporate Secretary of Allogene Therapeutics, Inc. (ALLO), an advisor to Vida Ventures, LLC, a life science investment firm. David received his B.A. from The George Washington University and his J.D. from Fordham University School of Law, where he has served on the Dean’s Planning Council since 2009.
Register for Updates
Two River 689 Fifth Avenue, 12th Floor New York, New York 10022 212.871.7900
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.